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regimens, NO major and one significant minor bleed have been observed in 
hospital in 62 patlonto. 
Conclusions: IV RPR 109891 aohleved plotolet inhibition with a cl~ar 
close,response and deoervos further study as part of a continuous IV followed 
by 0ral strategy for treatment of acute coronary syndromes, 
~ SulltalnSd Plstelet OP lib/Ills Blookeds With Oral 
Orboflbnn: Interim 8arMy end Tolersblllty 
Rolultl of the SOAR Study 
P,C, Oeadw(knie, J,J, Ferguson, O,J, Karalakas, D, Fit=gerald, R,J, Andare, 
O,M, Bum0, 0,8, Bryx~nnkt, VA M~lcal Center/University of California San 
Fran¢l#¢'o $¢hool of M~l¢lna, Frt~no, CA; G, D, Saarlo ~ Co, SkOklO, IL, 
USA 
~/,ground: SOAR ~tlfaty of ~Kooflban in ~cute Coronary _~esoeroh) is ¢1 
ran~iomized, plocebo.c0ntrollod study comparing four dosage levels of the 
oral platelet OP lib/Ills Inhibitor Orboflban to placebo In p~tlonts hospitalized 
with unstable angina (~,(~ houm but E120 hour~) or myocardial Infamtlon, 
P~tiants (n ~ 259) worn randomized to receive O~ofiben (~0, 40, 50 mo BlO 
or 60 mg QD) or pl~oebo for up to 3 months, All patients ~elvad conoomitant 
asptnn (162 mo/~ay), 
M~fhoo~: Patlento wsr~ aase8t~od for ~dvor~e ovont~ (AE) ~nd bloedlng 
events (BE) during Initlal hospltall,atlon and at follow up visits, 
Ro#glt~: At the time of this Inform an~lysis, there wero a total o! 1:]0 
patients completing a minimum of 1 month tro~tmant, The withdrawal rates 
w~m a8 follows: 
P ~10 10 40 010 50 0tO f~0 qO 
BE withdrawal (%) 0 1 (1%) = (4%) O ~ (4%) 
AlE withdr~wtt (%) 4 (9%~) 9 (10%) e (11%) 6..(le%) 6 (1~%) 
Ble(~ling ovents by treatment ware as follow~; 
P 30 810 40 8i0 50 010 50 QD 
Instgnl~nl 4 ? 7 10 4 
MII¢I t ~ 6 4 7 
8ev~r~ O I 0 O 0 
TOlill (%) 5 (12) 10 (20) 13 (28) 14 (31) 11 (24) 
Conclusion: Ofooflbsn produced dose-related increases in insignificant 
and mild bleeding events but was well tolerated uring ~hronic therapy. 
• Primary Reperfuslon in Acute Myocardial 
Infamtlon With RooPro and Heparln: Interim 
Results of ReoMI Pilot Study 
R. Makkar, N. Elgiar, ~, Gaff, E. F~/, L. ~arr, C. O'Haem, 1". Fisch011, 
F, Lltvack, Cedat~.Sin~ti Medical Center, Los Angeles, CA, USA 
R~oMI (RaoPre In MiD is a multlcenter pilot study to assess the efficacy 
of ReoPro In attaining primary ropertuslon in acute myOcardial Infamtlon. 
Patients w~th acute Q, wava MI, pmsenUng within 6 hours of chest pain are 
treated with aspirin (325 mg po), heparln (70 u/k9 iv) and ReoPro bolus (0.25 
rng/kg iv) followed by continuous infusion (0,10 mg/~g) in the emergency 
room. All patients undergo acute coronary anglography and intervention if 
clinically indicated, Primary end point is ability to attain TIMI grade It or III 
flow at anglogrsphy. Secondary endbeints include acute procedural success 
rate, in-hospital death, relnfar¢tlon, emergency re-intervention and bleeding 
c~mplicatiens. At the time el submission 20 patients (mean age 57 y, 17 
males) from 6 centers have been enrolled in the study, Average time between 
administration ofReoPro and baseline angiogram was 42 minutes. 
TIMI flows at baseline angiogaphy wore as follows: 
TIMI O: 8/20, TIMI t: 7120, TIMI Ih 2/20, TIMI II1:3/20 
Time between ReoprO and angiogram: 
<30 minutes: TIMI It or III flow in 0~11 patients 
->30 minutes: TIMI II Or III flow in 519 patients 
Corenaw intervention was successfully pedormed in 19 patients. Com- 
posite secondary endpoints of death (1), recurrent MI (0), emergent revas- 
cularization (1) and significant bteedin9 complications (2) occurred in 3/20 
patients. One month follOwup data will be presented. 
Conclusion: In~,3rim analysis suggest; that F,eoMI strategy ields TIMI Will 
flow in less than 50% patients, though repertusion may be time dependent. 
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~ Effloscy of Strategy for Menngsmlnt Invoslve the 
of the Isost.lnfamtlon Gero'loganlg IBho~k 
H, P~iroz.Coatolisno, J,A, Oorrono, J, Eli~O9a, E,J, O~r¢(o, 
J,L, LOpez,SendOn, J L, Oalodn, "Orc~orto MataP~n" General klOi~tal, 
Ma~lrld, Spain 
B~ckgmun#: Primary angloplasty 6~ma to improve the progn~t8 of Ix~t, 
infarction ¢afdlogonlo Shock (Ca), Our aim was to evaluate whether inva~ 
m~nagament of saute myoca~ial infarction (AMID ¢ompli~t~l with CS r~ 
duces the in*hoepitt~l mo~lolity, 
Matinee: From 1651 I~ttont~ with AMI admitted to o~r Corof~ly C~,  
Unit from J~nu~ry 19~4 to April t~19T, t~l  I~tionta (0~4%) d0Vol¢~ C~ 
unrelated to mechanical ¢0mpllc~ti~ns, The MratoOy of manp0omont w~ 
¢onslde~d tnvaoivo if a ¢OrOna~ angiography Ontanding to r~ve~ulan~.eD 
w~s In,looted in the fi~t 24 hours alter the coronary e,,~nt ovoIvi~l in C$, 
I~very other strategy, including throt~l~ly$ie, woo considered ¢olls~/atiw, 
Fo~.thr~ ~tient8 who developed CS tn~idiously w~re exolud~l, bocau'~) 
e definite vent which ¢ou!d (~t~ to e cattain aOfUAtiO~ at a partiojIM moment 
gould not b~ Indonti!i~, 
R~sgI~: Nlnety.alx p~tiente we~ i~lude(J, The atlategy was invssive in 
6t patients (64%D and ¢onsewativ~ in 31 (~,%); four i~tlent~ (4%D were 
unolassift~;J k~ocaosa they died ~ihortly after their admission, The in-hosl~n! 
mortality Of the invasive strategy wee lower than the consorv~zSve (70 vs. 90%; 
OR 0,3 [0.1-,0.6]; p < 0,05). However, alter adjusting by other pred¢tora 
of mortality, such as age and prior ischemio heart disease, the strategy 
of management was not en tndel~ndent predictor of in-hospltal me.Sty 
(Table), 
In,,~o~tat,m~, alay OR C195% P 
Age (OR per 5 year increase) 155 1.15--2.10 0003 
Prior tschemi¢ h~rt diso~zo 3.30 1 O7-11.11 0.04 
I nWSW~ strategy 0.81 O. 15"..3.65 0.78 
Conclusions: The lower mortality o! patients managed invasively might 
be due to betng younger, having less prior ischemic disease or other factors 
rather than the efficacy inherent o the treatment. The role of invasive strategy 
of post.infarrion CS needs further evaluation. 
j i029:i sO [ o.e Year su,~lv= Amo.g ~tio.to With 
Myocarcllal Infarction Complicated by 
Cardlogenlc Shock Alive at 30 Says, and the 
Impact of Early Revascuierization: Results From 
GUSTO-1 
P.B. Berger, R. Tuttis, D.R, Holmes, Jr.. The GUSTO.I Investigators. Mayo 
Clinic, Rochester MN, USA 
Thirty-day Survival is increased in p~tlents (pts) with myOcardial infarction (MI) 
complicated by cardiogenic shock who undergo eady revascularizaben, even 
after adjusting for differences in baseline characteristics and other sources of 
bias. However. longer term survival rates and the duration of benefit of eady 
revascularization are unknown, We analyzed 30-day survivors in GUSTO-t 
and identified 1321 pts who had had shock (Group 1) and 36,333 who did not 
(Group 2). Group 1 pts were older and sicker in many ways. At 1 yr, 88.0% 
Of Group 1 were alive vs 97.4% of Group 2 (p = 0.0001). Among Group 1 
pts, 44% had undergone revascularizarion within 30 days (Group 1A), and 
56% had not (Group 1B). At 1 yr, 91.7% of Group 1A pts were alive vs 85.3% 
Of Group 18 (p = 0,0001), Multivariate logistic regression analysis of Group 
1 pts revealed that revascularization within 30 days of MI was an important 
independent predictor of survival to 1 yr (odds ratio 0.41 [0.25, 0.67], p = 
0.0001). 
Conclusions: Among pt.~ with MI complicated by shock, most who sur- 
vive 30 days (L3%) are alive at 1 year. Eady revascularization isassociated 
with improved survival in shock pts for at least 1 year, even among 30-day 
survivors. The high survival rate and persistent benefits of eady revascular- 
ization Support an oath, aggressive revascularization strategy among such 
pts. 
